Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Smith (Birmingham, United Kingdom). Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome?. Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level

Member's Comments

No comment yet.

Related content which might interest you: IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 Can we predict tuberculosis cure? What tools are available? Source: Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018 Year: 2018 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 IP-10 point-of-care tests for monitoring treatment efficacy in tuberculosis in a low-resource setting Source: International Congress 2017 – Update on TB: latest news Year: 2017 Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Source: Eur Respir J 2010; 36: 870-877 Year: 2010 Diagnostic culture confirmation and bacteriological evidence of cure in English adult TB cases: Can we do better? Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Improved diagnostic evaluation of suspected tuberculosis in routine practice Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Which clinical variables best predict asthma control? Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 Pre-chemotherapy drug sensitivity test for antitubercular drugs in India – is it essential? Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Do we need bacteriological confirmation of cure in uncomplicated tuberculosis? Source: Eur Respir J 2013; 42: 860-863 Year: 2013 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011